Warner Chilcott Buyout Values Women’s Health Rx Firm At $3 Bil.
This article was originally published in The Pink Sheet Daily
Executive Summary
Buyout by DLJ and J.P. Morgan investment groups will complete transformation of U.K. company into U.S.-focused specialty women’s health firm. Investor group plans to retain current Warner Chilcott management following sale.